Señales en vivo de LRMR | Maximiza tus Ganancias con Getagraph.com

COMPRAR 111703 min ago

@ $11.62

Emitido: 14 feb 2024 @ 13:41

Retorno: -36.72%

Señal anterior: feb 13 - 15:50

Señal anterior: Vender

Retorno: 25.70 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform...

Stats
Volumen de hoy	384 344
Volumen promedio	656 827
Capitalización de mercado	468.93M
EPS	$0 ( 2024-03-12 )
Próxima fecha de ganancias	( $-0.240 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.75
ATR14	$0.0150 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-16	Flynn James E	Buy	1 430 206	Common Stock
2024-02-16	Flynn James E	Buy	1 430 206	Common Stock
2024-02-16	Flynn James E	Buy	1 430 205	Common Stock
2024-02-14	Thomas Frank E	Buy	2 000	Common Stock
2024-01-17	Shankar Gopi	Buy	135 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 91 transactions
Buy: 20 937 267 \| Sell: 6 152 661

Volumen Correlación

Largo: 0.06 (neutral)

Corto: 0.28 (neutral)

Signal:(30.763) Neutral

Larimar Therapeutics Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Larimar Therapeutics Inc Correlación - Moneda/Commodity

-0.12
( neutral )

-0.13
( neutral )

0.00
( neutral )

-0.03
( neutral )

0.01
( neutral )

Larimar Therapeutics Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-311 000 (0.00 %)
EPS:	$-0.840

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-311 000 (0.00 %)
EPS:	$-0.840

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-272 000 (0.00 %)
EPS:	$-1.330

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-4.26

Financial Reports:

No articles found.

Larimar Therapeutics Inc

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.